NCT02505334 - A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus. | Biotech Hunter

Enrollment

635

Participants

Timeline

Start Date

July 21, 2015

Primary Completion Date

May 2, 2017

Study Completion Date

November 9, 2017

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

liraglutide

Injected subcutaneously s.c. (under the skin) once daily.

Trial Locations (47)

5590012

Novo Nordisk Investigational Site, Osaka-shi, Osaka

379 0116

Novo Nordisk Investigational Site, Annaka-shi, Gunma

066-0032

Novo Nordisk Investigational Site, Chitose, Hokkaido

103-0027

Novo Nordisk Investigational Site, Chuo-ku Tokyo

103 0002

Novo Nordisk Investigational Site, Chuo-ku, Tokyo

103 0027

Novo Nordisk Investigational Site, Chuo-ku, Tokyo

104 0061

Novo Nordisk Investigational Site, Chūōku

Unknown

Novo Nordisk Investigational Site, Fukuoka-shi, Fukuoka

Novo Nordisk Investigational Site, Higashiosaka-shi, Osaka

Novo Nordisk Investigational Site, Ichikawa-shi, Chiba

Novo Nordisk Investigational Site, Kobe-shi, Hyogo

Novo Nordisk Investigational Site, Mito-shi, Ibaraki

Novo Nordisk Investigational Site, Neyagawa-shi, Osaka

078-8236

Novo Nordisk Investigational Site, Hokkaido

358 0011

Novo Nordisk Investigational Site, Iruma-shi, Saitama

598 0048

Novo Nordisk Investigational Site, Izumisano

582 0005

Novo Nordisk Investigational Site, Kashiwara-shi, Osaka

350 0851

Novo Nordisk Investigational Site, Kawagoe-shi, Saitama

862 0976

Novo Nordisk Investigational Site, Kumamoto-shi,Kumamoto

310-0845

Novo Nordisk Investigational Site, Mito-shi, Ibaraki

880 0034

Novo Nordisk Investigational Site, Miyazaki

311 0113

Novo Nordisk Investigational Site, Naka-shi, Ibaraki

662 0971

Novo Nordisk Investigational Site, Nishinomiya-shi, Hygo

663-8501

Novo Nordisk Investigational Site, Nishinomiya-shi, Hyogo

831 0016

Novo Nordisk Investigational Site, Okawa-shi, Fukuoka

553 0003

Novo Nordisk Investigational Site, Osaka-shi, Osaka

323 0022

Novo Nordisk Investigational Site, Oyama-shi, Tochigi

870 0039

Novo Nordisk Investigational Site, Ōita

849 0937

Novo Nordisk Investigational Site, Saga-shi,Saga

060 0062

Novo Nordisk Investigational Site, Sapporo-shi, Hokkaido

060-0001

Novo Nordisk Investigational Site, Sapporo-shi, Hokkaido

062 0007

Novo Nordisk Investigational Site, Sapporo-shi, Hokkaido

060 8648

Novo Nordisk Investigational Site, Sappro-shi, Hokkaido

329 0433

Novo Nordisk Investigational Site, Shimotsuke-shi, Tochigi

160-0008

Novo Nordisk Investigational Site, Shinjuku-ku, Tokyo

424 0853

Novo Nordisk Investigational Site, Shizuoka

565-0853

Novo Nordisk Investigational Site, Suita-shi, Osaka